Diskussionsleitung: A. Mügge (Bochum), P. Wenzel (Mainz)
(P1838) | Performance of STOP-BANG Questionnaire as sleep apnoea screening tool in patients with atrial fibrillation referred to a virtual remote sleep apnoea management pathway | |
K. Betz, D.V.M. Verhaert, M. Gawalko, A.N.L. Hermans, N. Pluymaekers, R. Van der Velden, S. Philippens, B. Vorstermans, S.O. Simons, D.W. den Uijl, S.-M. Chaldoupi, J.G.L.M. Luermans, S.W. Weestra, T. Lankveld, K. Kadhim, J.-L. Pepin, R. van Steenwijk, B. Hol, U. Schotten, P. Sanders, K. Vernooy, J. M. Hendriks, D. Linz (Aachen; Maastricht, Nijmegen, Amersfoort, NL; Adelaide, AU; Grenoble, FR) | ||
(P1839) | Effects of Empagliflozin on Markers of Calcium and Phosphate Homeostasis in Patients with Type 2 Diabetes – Data from a Randomized, Placebo-controlled Study | |
M. Rau, K. Thiele, N.-U. Hartmann, J. Möllmann, S. Wied, M. Hohl, N. Marx, M. Lehrke (Aachen, Homburg/Saar) | ||
(P1840) | Determinants of the 6-minute walk distance and association with cardiac function in the general population – Results from the STAAB cohort study | |
N. Moser, F. Sahiti, V. Cejka, M. Kohls, J. Albert, S. Frantz, F. Eichner, S. Störk, P. U. Heuschmann, G. Gelbrich, C. Morbach, für die Studiengruppe: STAAB (Würzburg) | ||
(P1841) | Profiles of comorbidity as an important risk modifier in patients discharged after an episode of acutely decompensated non-systolic heart failure | |
J. Albert, N. Seer, N. Scholz, F. Sahiti, V. Cejka, U. Stefenelli, C. Morbach, G. Ertl, C. E. Angermann, S. Störk (Würzburg) | ||
(P1842) | Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus | |
H. Fröhlich, A. Bossmeyer, S. Kazmi, K. Goode, S. Agewall, D. Atar, N. Frey, J. Cleland, L. Frankenstein, A. Clark, T. Täger (Heidelberg; Hull, Glasgow, UK; Oslo, NO) | ||
(P1843) | Association of congestion with body composition analysis in patients with heart failure | |
T. Garfias Macedo, D. Al-Mudaris, M. Vatic, G. Loncar, W. Döhner, S. D. Anker, S. von Haehling, für die Studiengruppe: SICA-HF (Göttingen, Berlin; Belgrade, SRB) | ||
(P1844) | Relationship between functional pulmonary phenotypes and left ventricular function in chronic heart failure – Results from the MyoVasc Study | |
M. Heidorn, A. Schuch, F. Müller, S.-O. Tröbs, G. Buch, A. Schulz, S. Schwuchow-Thonke, D. Velmeden, K. Lackner, K. Strauch, I. Schmidtmann, T. Gori, T. Münzel, J. Prochaska, P. S. Wild, für die Studiengruppe: DZHK (Mainz) | ||
(P1845) | Relevance of diffusion capacity of the lungs for carbon monoxide for clinical outcome in chronic heart failure – Results from the MyoVasc study | |
M. Heidorn, F. Müller, A. Schuch, G. Buch, A. Schulz, D. Velmeden, J. Söhne, K. Lackner, T. Gori, T. Münzel, P. S. Wild, J. Prochaska, für die Studiengruppe: DZHK (Mainz, Mainz,) |